WY-14643, a Potent Peroxisome Proliferator Activator Receptor-α PPAR-α Agonist Ameliorates the Inflammatory Process Associated to Experimental Periodontitis
2010

WY-14643 Reduces Inflammation in Periodontitis

Sample size: 20 publication 10 minutes Evidence: moderate

Author Information

Author(s): Briguglio Enrico, Di Paola Rosanna, Paterniti Irene, Mazzon Emanuela, Oteri Giacomo, Cordasco Giancarlo, Cuzzocrea Salvatore

Primary Institution: Universita degli Studi di Messina

Hypothesis

Can the PPAR-α agonist WY14643 reduce inflammation in a rat model of periodontitis?

Conclusion

The study found that WY14643 significantly decreased inflammation and tissue damage in rats with periodontitis.

Supporting Evidence

  • WY14643 treatment reduced myeloperoxidase activity, indicating less inflammation.
  • Cytokines TNF-α and IL-1β levels were significantly lower in treated rats.
  • Histological analysis showed reduced tissue damage in the gingivomucosal tissues of treated rats.
  • Treatment with WY14643 prevented IκB-α degradation, indicating reduced NF-κB activation.
  • Positive staining for iNOS was abolished in gingivomucosal tissues from treated rats.
  • Radiographic analysis showed less bone resorption in the treated group.

Takeaway

This study shows that a drug called WY14643 can help reduce swelling and damage in the gums of rats with gum disease.

Methodology

Male Sprague-Dawley rats were treated with WY14643 for eight days after inducing periodontitis with ligature, and various inflammatory markers were assessed.

Limitations

The study was conducted in a rat model, which may not fully replicate human periodontitis.

Participant Demographics

Male Sprague-Dawley rats, weighing 280-400g.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1155/2010/193019

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication